These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9879389)

  • 1. [Drug therapy of obesity].
    Wechsler JG
    Acta Med Austriaca; 1998; 25(4-5):138-41. PubMed ID: 9879389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of obesity. Past, present, and future.
    Wangsness M
    Minn Med; 2000 Nov; 83(11):21-6. PubMed ID: 11126476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sibutramin in obesity treatment (multicenter, open, prospective 12-month-long study)].
    Payer J; Hainer V; Ondrejka P; Kajtor Z
    Vnitr Lek; 2004 Nov; 50(11):825-9. PubMed ID: 15648961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of obesity.
    Linné Y; Rössner S
    Clin Dermatol; 2004; 22(4):319-24. PubMed ID: 15475233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sibutramine-associated adverse effects: a practical guide for its safe use.
    Florentin M; Liberopoulos EN; Elisaf MS
    Obes Rev; 2008 Jul; 9(4):378-87. PubMed ID: 18034790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appetite suppressants as adjuncts in the treatment of obesity.
    Elks ML
    J Fam Pract; 1996 Mar; 42(3):287-92. PubMed ID: 8636681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine: new preparation. Slight weight loss; but also a slight rise in blood pressure ..
    Prescrire Int; 2001 Oct; 10(55):140-5. PubMed ID: 11824428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
    Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does drug therapy of obesity have a future?
    Trakas K; Leiter L; Shear NH
    Can J Clin Pharmacol; 2000; 7(3):133-4. PubMed ID: 11044757
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity.
    Arterburn D
    Clin Evid; 2002 Jun; (7):538-47. PubMed ID: 12230679
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia].
    Rajzer M; Wojciechowska W; Kawecka-Jaszcz K
    Przegl Lek; 2004; 61(2):94-8. PubMed ID: 15230149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of antiobesity drugs.
    Galloway SM; Farquhar DL; Munro JF
    Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.